CHINA RESOURCES PHARMACEUTICAL GR earnings per share and revenue

3320 earnings per share for the last semiannual are 0.18 HKD whereas the estimation was 0.21 HKD which accounts for -11.20% surprise. Company revenue for the same period amounts to 123.85 B HKD despite the estimated figure of 138.88 B HKD. Estimated earnings per share for the next semiannual are 0.48 HKD, and revenue is expected to reach 142.87 B HKD. Also watch annual changes over time to get a bigger picture of 3320 earnings per share and revenue dynamics.